|
Volumn 52, Issue 11, 2011, Pages 2133-2138
|
International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy
d
CHU BRETONNEAU
(France)
|
Author keywords
Consensus; Delphi process; Epilepsy; Intellectual disability; Neuropsychiatric disorder
|
Indexed keywords
ANTICONVULSIVE AGENT;
ANTIDEPRESSANT AGENT;
CARBAMAZEPINE;
FLUOXETINE;
FLUVOXAMINE;
LAMOTRIGINE;
LITHIUM;
NEUROLEPTIC AGENT;
OXCARBAZEPINE;
SEROTONIN UPTAKE INHIBITOR;
VALPROIC ACID;
ADOLESCENT DISEASE;
ANTICONVULSANT THERAPY;
ANXIETY DISORDER;
ARTICLE;
BRAIN DISEASE;
CHILDHOOD DISEASE;
CLINICAL PRACTICE;
COGNITIVE DEFECT;
COGNITIVE THERAPY;
DELPHI STUDY;
DEPRESSION;
DISEASE ASSOCIATION;
ELECTROCONVULSIVE THERAPY;
EPILEPSY;
HEALTH CARE QUALITY;
HUMAN;
MENTAL DISEASE;
NEUROLOGIC DISEASE;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PSYCHOEDUCATION;
PSYCHOPHARMACOTHERAPY;
PSYCHOSIS;
SCHIZOPHRENIA;
SUICIDE;
ADOLESCENT;
ADULT;
ANXIETY DISORDERS;
CHILD;
COGNITION DISORDERS;
DEPRESSIVE DISORDER;
EPILEPSY;
HUMANS;
INTELLECTUAL DISABILITY;
MENTAL DISORDERS;
PRACTICE GUIDELINES AS TOPIC;
PSYCHOTIC DISORDERS;
|
EID: 80255138221
PISSN: 00139580
EISSN: 15281167
Source Type: Journal
DOI: 10.1111/j.1528-1167.2011.03276.x Document Type: Article |
Times cited : (291)
|
References (7)
|